Concerta Adverse Events Update On “Drug Watch” Web Site Advised By Cmte.
Executive Summary
FDA should consider posting concerns about psychiatric and cardiovascular adverse events with Johnson & Johnson's Concerta and other methylphenidate products on the agency's upcoming "Drug Watch" website, members of FDA's Pediatric Advisory Committee said
You may also be interested in...
Suicidality Risk With ADHD Drugs Should Be Treated As Class Effect – Cmte.
The risk of suicidality in children receiving drugs to treat attention deficit/hyperactivity disorder should be viewed as a class effect, FDA's Pediatric Advisory Committee recommended March 22
Suicidality Risk With ADHD Drugs Should Be Treated As Class Effect – Cmte.
The risk of suicidality in children receiving drugs to treat attention deficit/hyperactivity disorder should be viewed as a class effect, FDA's Pediatric Advisory Committee recommended March 22